[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353860-105":59,"doc-detail-353860-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","trends-and-future-projections-of-cancer-prevalence-in-patients-with-cardiovascular-admissions","Trends and future projections of cancer prevalence in patients with cardiovascular admissions","","Patients with cancer face elevated cardiovascular risk, yet future patterns of cancer prevalence among people hospitalized for acute cardiovascular conditions remain insufficiently characterized. This study analyzed US National Inpatient Sample admissions (2016–2020) with primary cardiovascular diagnoses to assess cancer prevalence trends and forecast co-morbidity through 2040 using regression-based modeling. Cancer prevalence increased from 4.8% to 5.4% and is projected to reach 11.9% by 2040, with substantial growth across multiple cancer types.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/trends-and-future-projections-of-cancer-prevalence-in-patients-with-cardiovascular-admissions/353860/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/trends-and-future-projections-of-cancer-prevalence-in-patients-with-cardiovascular-admissions/353860.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study?","Question",{"text":112,"@type":113},"To evaluate trends in cancer prevalence among patients admitted for cardiovascular conditions and to predict future cancer and cardiovascular co-morbidity over the next 20 years.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data source and timeframe were used?",{"text":117,"@type":113},"All US hospital admissions with a primary cardiovascular diagnosis from the National Inpatient Sample were included for 2016 to 2020.",{"name":119,"@type":110,"acceptedAnswer":120},"How much is cancer prevalence projected to change by 2040?",{"text":121,"@type":113},"Cancer prevalence in cardiovascular inpatients is projected to rise from 4.8% in 2016 to 11.9% by 2040, representing a substantial increase in predicted burden.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353860,1790898505,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","European Heart Journal Open (2026) 6, oeag030 [https://doi.org/10.1093/ehjopen/oeag030](https://doi.org/10.1093/ehjopen/oeag030)  \nORIGINAL ARTICLE  \nSpecial populations  \nTrends and future projections of cancer prevalence in patients with cardiovascular admissions  \nGuia Ferrari Ardicini  1,2, Andrija Matetic  1,3, Evangelos Kontopantelis  4,5, Alaide Chieffo2,6, Carmen Maria Moldovan7, Zahra Raisi-Estabragh8, Elad Asher9, Christian Mallen10, and Mamas A. Mamas  1,11,12,*  \n1Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Keele ST5 5BG, UK; 2Vita-Salute San Raffaele University, Via Olgettina 58, 20132 Milan, Italy; 3Department of Cardiology, University Hospital of Split, Spinciceva 1, 21000 Split, Croatia; 4Division of Informatics, Imaging and Data Science, The University of Manchester, Oxford Road, Manchester M13 9PL, UK; 5Division of Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, 119228 Singapore, Singapore; 6Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy; 7The 3rd Department of Cardiology, University of Athens, Sotiria Hospital, Mesogeion Avenue 152, 11527 Athens, Greece; 8Centre for Advanced Cardiovascular Imaging, William Harvey Research Institute, Queen Mary University of London, NIHR Barts Biomedical Research Centre, Barts Heart Centre, Barts Health NHS Trust, Charterhouse Square, London EC1M 6BQ, UK; 9Jesselson Heart Center, Shaare Zedek Medical Center, The Eisenberg R&D Authority, and Faculty of Medicine, Hebrew University of Jerusalem, 12 Bayit Street, Jerusalem 91031, Israel; 10School of Medicine, Keele University, Keele, Staffordshire ST5 5BG, UK; 11Royal Stoke University Hospital, Newcastle Road, Stoke-on-Trent ST4 6QG, UK; and 12National Institute for Health and Care Research (NIHR), Birmingham Biomedical Research Centre, Mindelsohn Way, Birmingham B15 2TQ, UK  \nReceived 21 November 2025; revised 23 January 2026; accepted 17 February 2026; online publish-ahead-of-print 19 February 2026 Handling Editor: Magnus Bäck  \nAims Patients with cancer have an increased risk of cardiovascular (CV) events, although there is limited data on fu  \nture trends in cancer prevalence amongst patients with an acute cardiovascular admission. The aim of this study was to evaluate trends in cancer prevalence among CV admissions with an attempt to predict future cancer and CV co-morbidity over the next 20 years.  \nMethods The analysis included all hospital admissions with a primary CV diagnosis from the US National Inpatient  \nand results Sample (NIS), from 2016 to 2020. The sample was stratified by specific CV admission and by cancer status  \nand type. The chi-square and the Kruskal–Wallis tests were used to compare categorical and continuous data, respectively, across the years. A Poisson regression model was used to predict the prevalence of overall and specific cancer types through 2040, based on the 5-year baseline period. Among 4.79 million CV admissions from 2016 to 2020, there was a significant increase in cancer prevalence from 4 .8% to 5 .4%(P \u003C 0 .001) . This upward trend was observed across all CV diagnoses. Predictive modelling estimates that cancer prevalence in CV inpatients will increase from a 4.8% baseline in 2016 to 11.9% by 2040, with the most pronounced rate of growth seen in liver (IRR 1.069; P \u003C 0.001), breast (IRR 1.056; P \u003C 0.001), and renal cancer (IRR 1.055; P \u003C 0 .001) . Nevertheless, haematological and lung cancers show the highest prevalence, both at baseline and in 2040.  \nConclusion The prevalence of cancer among patients hospitalized with CV disease is predicted to increase 2.48-fold  \nby 2040. This trend highlights the importance of integrated cardio-oncology and multidisciplinary care models.  \nLay Summary Heart disease and cancer are two of the leading causes of death worldwide. As they share many risk factors, as cancer survival continues to impr","cbCaiurSkoAWQzND","https://ap.wps.com/l/cbCaiurSkoAWQzND","pdf",1158716,18,"English","# Aims\n# Methods\n# Results\n# Conclusion\n# Lay Summary\n## Keywords","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To evaluate trends in cancer prevalence among patients admitted for cardiovascular conditions and to predict future cancer and cardiovascular co-morbidity over the next 20 years.\"},{\"question\":\"Which data source and timeframe were used?\",\"answer\":\"All US hospital admissions with a primary cardiovascular diagnosis from the National Inpatient Sample were included for 2016 to 2020.\"},{\"question\":\"How much is cancer prevalence projected to change by 2040?\",\"answer\":\"Cancer prevalence in cardiovascular inpatients is projected to rise from 4.8% in 2016 to 11.9% by 2040, representing a substantial increase in predicted burden.\"}]","Trends and future projections of cancer prevalence in patients with cardiovascular admissions | PDF",1790107635,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5045266bee3eb794cac2dae3a5236e7.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e74f065108e1aa4216a9f544249306a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff7dcb38da644314ab374852c4d93d8f.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7ad58a3b00a53fa0907399a7f1b7615.webp",980,1306]